D'Errico M, Calcagnile A, Canzona F, Didona B, Posteraro P, Cavalieri R, Corona R, Vorechovsky I, Nardo T, Stefanini M, Dogliotti E
Laboratory of Comparative Toxicology and Ecotoxicology, Istituto Superiore di Sanita, Rome, Italy.
Oncogene. 2000 Jan 20;19(3):463-7. doi: 10.1038/sj.onc.1203313.
Molecular analysis of p53 and patched (PTCH), two candidate tumor suppressor genes for non-melanocytic skin cancer, was performed in skin tumors from six patients affected by the cancer-prone disease xeroderma pigmentosum (XP). UV-specific p53 mutations were detected at a frequency of 38-50% in all the tumor types analysed, including melanomas. Additional analysis of PTCH mutations in the subset of eight basal call carcinomas (BCC) revealed a very high mutation frequency of this gene (90%) which exceeded that detected in the p53 gene in the same tumors (38%). PTCH mutations were predominantly UV-specific C>T transitions. This mutation pattern is different from that reported in BCC from normal donors where PTCH mutation frequency is 27% and mutations are frequently deletions and insertions. These findings suggest that PTCH mutations represent an earlier event in BCC development than p53 alterations and that the inability of XP patients to repair UV-induced PTCH mutations might significantly contribute to the early and frequent appearance of BCC observed in these patients.
对p53和patched(PTCH)这两个非黑素细胞性皮肤癌候选抑癌基因进行了分子分析,这两个基因来自6名患有易患癌症疾病色素性干皮病(XP)的患者的皮肤肿瘤。在包括黑色素瘤在内的所有分析的肿瘤类型中,紫外线特异性p53突变的检测频率为38%-50%。对8例基底细胞癌(BCC)子集的PTCH突变进行的额外分析显示,该基因的突变频率非常高(90%),超过了在相同肿瘤中p53基因检测到的频率(38%)。PTCH突变主要是紫外线特异性的C>T转换。这种突变模式与正常供体的BCC中报道的不同,正常供体的BCC中PTCH突变频率为27%,突变经常是缺失和插入。这些发现表明,PTCH突变在BCC发展中比p53改变更早发生,并且XP患者无法修复紫外线诱导的PTCH突变可能显著促成了在这些患者中观察到的BCC的早期和频繁出现。